Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
A cohort study finds the risk for acne in patients on JAK inhibitors for atopic dermatitis was about 2.5 times greater than ...
When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...
Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
A new analysis of data from a large international consortium indicates that social and academic difficulties often arise ...
CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for ...
PONTE VEDRA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts (TMCI), Inc. , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related ...
SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...
New peer-reviewed research demonstrates breakthrough in early detection of adverse pregnancy outcomes for Medicaid patients, ...
According to GRI Bio, the data shows that GRI-0621 directly impacts the core biology of IPF, with differentially expressed genes linked to key disease drivers supporting a mechanism consistent with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results